Immunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical Outcome | Zendy

I. Jolanda M. de Vries | Zendy; Monique R. Bernsen | Zendy; W. Joost Lesterhuis | Zendy; Nicole M. Scharenborg | Zendy; S P Strijk | Zendy; MarieJeanne P. Gerritsen | Zendy; Dirk J. Ruiter | Zendy; Carl G. Figdor | Zendy; Cornelis J.A. Punt | Zendy; Gosse J. Adema | Zendy

Open Access

Immunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical Outcome

Author(s) -

I. Jolanda M. de Vries,

Monique R. Bernsen,

W. Joost Lesterhuis,

Nicole M. Scharenborg,

S P Strijk,

MarieJeanne P. Gerritsen,

Dirk J. Ruiter,

Carl G. Figdor,

Cornelis J.A. Punt,

Gosse J. Adema

Publication year - 2005

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2005.06.478

Subject(s) - keyhole limpet hemocyanin , medicine , antigen , immunotherapy , melanoma , immunology , vaccination , t cell , cytotoxic t cell , dendritic cell , delayed hypersensitivity , immune system , cancer research , in vitro , biology , biochemistry

Tumor-specific immunomonitoring is essential to evaluate the efficacy of vaccination against cancer. In this study, we investigated the predictive value of the presence or absence of antigen-specific T cells in biopsies from delayed-type hypersensitivity (DTH) sites.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research